191 related articles for article (PubMed ID: 16352914)
1. Role of chronic inhibition of dopamine-metabolizing enzymes in the regulation of renal sodium and phosphate excretion in the rat remnant kidney.
Sampaio-Maia B; Moreira-Rodrigues M; Pestana M
Nephron Physiol; 2006; 103(1):p14-24. PubMed ID: 16352914
[TBL] [Abstract][Full Text] [Related]
2. The role of dopamine-metabolizing enzymes in the regulation of renal sodium excretion in the rat.
Odlind C; Reenilä I; Männistö PT; Ekblom J; Hansell P
Pflugers Arch; 2001 Jul; 442(4):505-10. PubMed ID: 11510881
[TBL] [Abstract][Full Text] [Related]
3. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
[TBL] [Abstract][Full Text] [Related]
4. Different renal effects of two inhibitors of catechol-O-methylation in the rat: entacapone and CGP 28014.
Hansell P; Odlind C; Männistö PT
Acta Physiol Scand; 1998 Apr; 162(4):489-94. PubMed ID: 9597116
[TBL] [Abstract][Full Text] [Related]
5. Effect of inhibition of MAO and COMT on intrarenal dopamine and serotonin and on renal function.
Wang Y; Berndt TJ; Gross JM; Peterson MA; So MJ; Knox FG
Am J Physiol Regul Integr Comp Physiol; 2001 Jan; 280(1):R248-54. PubMed ID: 11124158
[TBL] [Abstract][Full Text] [Related]
6. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
[TBL] [Abstract][Full Text] [Related]
7. Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney.
Vieira-Coelho MA; Serrão P; Guimarães JT; Pestana M; Soares-da-Silva P
Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1033-44. PubMed ID: 11097621
[TBL] [Abstract][Full Text] [Related]
8. Sodium-dependent modulation of systemic and urinary renalase expression and activity in the rat remnant kidney.
Quelhas-Santos J; Sampaio-Maia B; Simões-Silva L; Serrão P; Fernandes-Cerqueira C; Soares-Silva I; Pestana M
J Hypertens; 2013 Mar; 31(3):543-52; discussion 552-3. PubMed ID: 23314744
[TBL] [Abstract][Full Text] [Related]
9. Role of monoamine oxidase and catechol-O-methyltransferase in the metabolism of renal dopamine.
Fernandes MH; Soares-da-Silva P
J Neural Transm Suppl; 1994; 41():101-5. PubMed ID: 7931214
[TBL] [Abstract][Full Text] [Related]
10. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
Huotari M; Passlin M; Nordberg HL; Forsberg M; Kotisaari S; Tuomisto L; Shintani F; Tanaka KF; Reenilä I; Laitinen K; Männistö PT
J Neurosci Methods; 2001 Aug; 109(1):47-52. PubMed ID: 11489299
[TBL] [Abstract][Full Text] [Related]
11. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
Männistö PT; Tuomainen P
Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
[TBL] [Abstract][Full Text] [Related]
12. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
[TBL] [Abstract][Full Text] [Related]
13. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
Okada M; Nakao R; Hosoi R; Zhang MR; Fukumura T; Suzuki K; Inoue O
J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: endogenous 5-hydroxytryptamine, 5-HT1A receptors and antinatriuresis during high sodium intake.
Soares-da-Silva P; Vieira-Coelho MA; Pestana M
Br J Pharmacol; 1996 Mar; 117(6):1193-8. PubMed ID: 8882615
[TBL] [Abstract][Full Text] [Related]
15. Changing dopaminergic activity through different pathways: consequences for renal sodium excretion, regional blood flow and oxygen tension in the rat.
Odlind C; Fasching A; Liss P; Palm F; Hansell P
Acta Physiol Scand; 2001 Jul; 172(3):219-26. PubMed ID: 11472309
[TBL] [Abstract][Full Text] [Related]
16. Effect of acute levodopa on brain catecholamines after selective MAO and COMT inhibition in male rats.
Männistö PT; Tuomainen P; Toivonen M; Törnwall M; Kaakkola S
J Neural Transm Park Dis Dement Sect; 1990; 2(1):31-43. PubMed ID: 2113389
[TBL] [Abstract][Full Text] [Related]
17. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
Eisenhofer G; Finberg JP
J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
[TBL] [Abstract][Full Text] [Related]
18. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
[TBL] [Abstract][Full Text] [Related]
19. Dopamine is metabolised by different enzymes along the rat nephron.
Ibarra FR; Armando I; Nowicki S; Carranza A; De Luca Sarobe V; Arrizurieta EE; Barontini M
Pflugers Arch; 2005 Jun; 450(3):185-91. PubMed ID: 15864503
[TBL] [Abstract][Full Text] [Related]
20. Reduced natriuretic response to acute sodium loading in COMT gene deleted mice.
Odlind C; Reenilä I; Männistö PT; Juvonen R; Uhlén S; Gogos JA; Karayiorgou M; Hansell P
BMC Physiol; 2002 Aug; 2():14. PubMed ID: 12188925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
